The Alliance News Center

Today’s Top News & Stories from Our Alliance Community
Hypothermia Kidney Transplant

Reduction in Delayed Kidney-Graft Function through Therapeutic Hypothermia

0

A study recently published in the New England Journal, discusses the use of therapeutic hypothermia in the care of organ donors and the impact on delayed kidney-graft function. Delayed graft function, is reported in up to 50% of kidney-transplant recipients and leads to increased healthcare costs and diminished long-term graft function. Dr. Claus Niemann from UC San Francisco and his study-team, randomly enrolled brain dead organ donors from two large donation service areas in to two temperature ranges: 34-35C (hypothermia) or 36.5-37.5C (normothermia).

The primary outcome evaluated was the rate of delayed graft function, which was defined as the need for dialysis during the first week post-transplantation. The secondary outcomes evaluated were the rates of individual organs transplanted in each group and the total number of organs recovered from each donor.

The study had to be terminated early, as the independent data and safety monitoring board, after interim analysis, recommended sufficient efficacy was demonstrated in the use of therapeutic hypothermia. The recommendations of the study are that targeted hypothermia in brain dead donors, can significantly reduce the rate of delayed graft function among recipients.

Reference:
Nieman CU, Feiner J, Swain S, et al. (2015). Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med, 373(5): 405-414. – article

Additional articles:
http://medicalxpress.com/news/2015-07-mild-hypothermia-deceased-donors-function.html
http://www.2minutemedicine.com/mild-hypothermia-for-deceased-organ-donors-reduces-the-rate-of-delayed-graft-function-in-renal-transplants/
http://www.renalandurologynews.com/transplantation/kidney-transplant-outcomes-better-if-donors-are-kept-in-hypothermia/article/429388/ (image)

Cell Transplants Contribute to Liver Regeneration
Pediatric Organ Donation Potential

Latest News

PR Carrotta KidneyXeno2024 072(1)

First-Ever Combined Heart Pump & Gene-Edited Pig Kidney Transplant Gives New Hope to Patient with Terminal Illness

TFC ABTC

ABTC/TFCA Finalize Testing Procedures for TFC Certification Exam

Macey Levan Profile

NYU Researcher Macey Levan’s True Service is in Cutting-Edge, High Impact Science that Moves the Needle for Transplant Patients, Living Donors, and Donor Families  

Screenshot 2024 04 04 At 5.10.51 PM

Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System

Care to Share?

Our community is full of good news. Please share yours. A great idea? An inspiring tale? A well-earned award? It’s OK to brag. We all could use good news. Would you like to nominate someone from your organization who goes above and beyond? We celebrate front line heroes. Please fill out our form to let us know.